Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.15 (-7.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Other Non-Current Liabilities (2024 - 2025)

Updated

Jyong Biotech's Other Non-Current Liabilities came in at $60,000 for the quarter ended Dec 31, 2025, up 3.4% from $58,000 a year earlier.

Analysis

Jyong Biotech (MENS) Other Non-Current Liabilities (2024 - 2025) Analysis & Trends

  • Going back by year, Other Non-Current Liabilities was $58,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Jyong Biotech 132.29 Mn 131.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.06 Mn
Jun 30, 2025 58,000.00
Dec 31, 2024 58,000.00
API Access

Jyong Biotech Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MENS&period=max&api_key=YOUR_API_KEY